News > India approves Roche/Regeneron antibody cocktail to treat COVID-19
India approves Roche/Regeneron antibody cocktail to treat COVID-19
Dais Newsfeed | 05/05/2021 09:57 PM | Click to read full article
India has given emergency use authorization for a COVID-19 antibody drug cocktail developed by Roche (ROG.S) and Regeneron (REGN.O), expanding its arsenal of drugs to battle a massive second wave of infections.
The therapy is a cocktail of two antibodies Casirivimab and Imdevimab, which are synthetically manufactured copies of antibodies that the body produces after an infection.